Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study

NCT01632904 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Polycythemia Vera

Interventions

DRUG: Ruxolitinib
DRUG: Hydroxyurea (HU)
DRUG: HU-placebo
DRUG: Ruxolitinib-placebo

Sponsor

Incyte Corporation